Company / Inventory
Anika Therapeutics, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$18.8M
FY2025
5-year range
$18.8M / $39.8M
FY2021-FY2025
Trend
-21.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory has declined for 3 consecutive years, from $40M in FY2022 to $19M in FY2025.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of -3.1%.
Declined from $24M to $19M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -22.1%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Anika Therapeutics, Inc.'s inventory has declined for 3 consecutive years.
- 5-year CAGR of -3.1%, indicating a declining trend.
- In FY2025, inventory decreased 21.1% year-over-year.
- Peak inventory was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.8M | -21.1% |
| FY2024 | $23.8M | -2.5% |
| FY2023 | $24.4M | -38.6% |
| FY2022 | $39.8M | +10.4% |
| FY2021 | $36.0M | +63.7% |
| FY2020 | $22.0M | +0.0% |
| FY2019 | $22.0M | +3.3% |
| FY2018 | $21.3M | -3.3% |
| FY2017 | $22.0M | +37.9% |
| FY2016 | $16.0M | +7.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026